Literature DB >> 12816730

Overexpression of tumor necrosis factor-alpha diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor-beta.

Masaki Fujita1, John M Shannon, Osamu Morikawa, Jack Gauldie, Nobuyuki Hara, Robert J Mason.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is thought to be important in the development of pulmonary fibrosis. However, surfactant protein-C/TNF-alpha transgenic mice do not spontaneously develop pulmonary fibrosis but instead develop alveolar enlargement and loss of elastic recoil. We hypothesized that overexpression of TNF-alpha in the lung requires an additional insult to produce fibrosis. In this study we evaluated whether TNF-alpha overexpression altered the development of pulmonary fibrosis due to bleomycin or transforming growth factor-beta (TGF-beta). Either 0.2 U bleomycin or saline was administered into left lung of TNF-alpha transgenic mice and their transgene-negative littermates. To overexpress TGF-beta, an adenovirus vector containing either active TGF-beta (AdTGF-beta) or LacZ was administered at a dose of 3 x 108 plaque-forming units per mouse. Fibrosis was assessed histologically and by measurement of hydroxyproline. TNF-alpha transgenic mice tolerated bleomycin or AdTGF-beta, whereas the transgene-negative littermates demonstrated severe pulmonary fibrosis after either agent. An increase in prostaglandin E2 and downregulation of TNF receptor I expression were observed in the TNF-alpha transgenic mice. In addition, recombinant human TNF-alpha attenuated bleomycin-induced pulmonary fibrosis. TNF-alpha has a complex role in the development of pulmonary fibrosis. Endogenous TNF-alpha may be important in the development of fibrosis as indicated in other reports, but overexpression of TNF-alpha or exogenous TNF-alpha limits pulmonary fibrosis in mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12816730     DOI: 10.1165/rcmb.2002-0046OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  41 in total

1.  TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis.

Authors:  Stephen K Frankel; Gregory P Cosgrove; Seung-Ick Cha; Carlyne D Cool; Murry W Wynes; Benjamin L Edelman; Kevin K Brown; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11-04       Impact factor: 6.914

Review 2.  Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Treat Respir Med       Date:  2006

3.  Loss of tumor necrosis factor alpha potentiates transforming growth factor beta-mediated pathogenic tissue response during wound healing.

Authors:  Shizuya Saika; Kazuo Ikeda; Osamu Yamanaka; Kathleen C Flanders; Yuka Okada; Takeshi Miyamoto; Ai Kitano; Akira Ooshima; Yuji Nakajima; Yoshitaka Ohnishi; Winston W-Y Kao
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

4.  Doxycycline attenuated pulmonary fibrosis induced by bleomycin in mice.

Authors:  Masaki Fujita; Qing Ye; Hiroshi Ouchi; Eiji Harada; Ichiro Inoshima; Kazuyoshi Kuwano; Yoichi Nakanishi
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

5.  Inflammation, oxidative stress and apoptosis cascade implications in bisphenol A-induced liver fibrosis in male rats.

Authors:  Sahar El-Sayed Elswefy; Fatma Rizk Abdallah; Hebatallah Husseini Atteia; Alaa Samir Wahba; Rehab Abdallah Hasan
Journal:  Int J Exp Pathol       Date:  2016-12-07       Impact factor: 1.925

6.  Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

Authors:  Elizabeth F Redente; Rebecca C Keith; William Janssen; Peter M Henson; Luis A Ortiz; Gregory P Downey; Donna L Bratton; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

7.  Tumour necrosis factor-alpha processing in interstitial lung disease: a potential role for exogenous proteinase-3.

Authors:  L Armstrong; S I H Godinho; K M Uppington; H A Whittington; A B Millar
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

8.  Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats.

Authors:  Manar Hamed Arafa; Nanies Sameeh Mohammad; Hebatallah Husseini Atteia; Hesham Radwan Abd-Elaziz
Journal:  J Physiol Biochem       Date:  2014-06-18       Impact factor: 4.158

Review 9.  Animal models of fibrotic lung disease.

Authors:  Bethany B Moore; William E Lawson; Tim D Oury; Thomas H Sisson; Krishnan Raghavendran; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

10.  Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats.

Authors:  Nejat Altintas; Mustafa Erboga; Cevat Aktas; Bulent Bilir; Murat Aydin; Aysun Sengul; Zehra Ates; Birol Topcu; Ahmet Gurel
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.